Hennion & Walsh Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.91M | Sell |
36,892
-910
| -2% | -$96.6K | 0.16% | 155 |
|
|
2025
Q1 | $4.69M | Buy |
37,802
+1,908
| +5% | +$237K | 0.21% | 107 |
|
|
2024
Q4 | $4.42M | Buy |
35,894
+4,332
| +14% | +$533K | 0.2% | 116 |
|
|
2024
Q3 | $3.52M | Buy |
31,562
+2,115
| +7% | +$236K | 0.16% | 158 |
|
|
2024
Q2 | $3.14M | Buy |
29,447
+4,183
| +17% | +$446K | 0.16% | 155 |
|
|
2024
Q1 | $3.04M | Buy |
25,264
+4,445
| +21% | +$535K | 0.16% | 168 |
|
|
2023
Q4 | $2.56M | Buy |
20,819
+5,394
| +35% | +$663K | 0.15% | 206 |
|
|
2023
Q3 | $2M | Buy |
15,425
+3,208
| +26% | +$415K | 0.13% | 217 |
|
|
2023
Q2 | $1.52M | Buy |
12,217
+2,935
| +32% | +$364K | 0.09% | 277 |
|
|
2023
Q1 | $1.36M | Buy |
9,282
+702
| +8% | +$103K | 0.08% | 288 |
|
|
2022
Q4 | $1.37M | Buy |
8,580
+2,149
| +33% | +$342K | 0.08% | 276 |
|
|
2022
Q3 | $857K | Buy |
6,431
+841
| +15% | +$112K | 0.06% | 363 |
|
|
2022
Q2 | $872K | Buy |
5,590
+671
| +14% | +$105K | 0.05% | 349 |
|
|
2022
Q1 | $766K | Sell |
4,919
-208
| -4% | -$32.4K | 0.04% | 407 |
|
|
2021
Q4 | $653K | Sell |
5,127
-1,335
| -21% | -$170K | 0.03% | 471 |
|
|
2021
Q3 | $841K | Sell |
6,462
-227
| -3% | -$29.5K | 0.04% | 390 |
|
|
2021
Q2 | $1.19M | Sell |
6,689
-266
| -4% | -$47.2K | 0.06% | 327 |
|
|
2021
Q1 | $1.14M | Buy |
+6,955
| New | +$1.14M | 0.07% | 335 |
|